SCHEMBL19865580

SCHEMBL19865580

O=C(O)c1cccc(-c2ccc(/C=N/NC3N=CC(F)=C(N4CCOCC4)N3)o2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 10/20 0.47
▸ MAPT P10636 9/20 0.47
▸ POLB P06746 7/20 0.47
▸ L3MBTL1 Q9Y468 7/20 0.47
▸ GAA P10253 3/20 0.47
▸ LDHA P00338 6/20 0.46
▸ ALDH1A1 P00352 5/20 0.46
▸ HPGD P15428 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ TDP1 Q9NUW8 4/20 0.45
▸ HTT P42858 2/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ AIMP2 Q13155 1/20 0.45
▸ G6PD P11413 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6721129 0.75 MAPT (0.65) KDM4EMAPTPOLBL3MBTL1GAA
SCHEMBL22903822 0.74 KDM4E (0.57) KDM4EMAPTPOLBL3MBTL1GAA
SCHEMBL13548901 0.74 MAPT (0.68) KDM4EMAPTPOLBL3MBTL1GAA
SCHEMBL17793849 0.71 MAPT (0.38) KDM4EMAPTPOLBL3MBTL1GAA
SCHEMBL6721172 0.69 MAPT (0.78) KDM4EMAPTPOLBL3MBTL1GAA
SCHEMBL19420133 0.65 MAPT (0.76) KDM4EMAPTPOLBL3MBTL1LDHA
SCHEMBL6721119 0.65 KDM4E (0.69) KDM4EMAPTPOLBL3MBTL1GAA
SCHEMBL19519001 0.64 KDM1A (0.43) KDM4EMAPTPOLBGAAALDH1A1
SCHEMBL6721166 0.64 MAPT (1.00) KDM4EMAPTPOLBL3MBTL1GAA
SCHEMBL6721168 0.64 MAPT (0.68) KDM4EMAPTPOLBL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180042935-A1 THERAMUTEIN MODULATORS HMI Medical Innovations, LLC 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180042935-A1 THERAMUTEIN MODULATORS TSG101, SERPINE1, PLAUR KDM4E 4221/4885MAPT 2984/4885POLB 2649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback